Background
cough, taste disturbances, RCC
RCC
P2X3 receptor antagonists seem to offer a promising potential for treating patients with refractory chronic cough (RCC) [A highly selective P2X3 receptor antagonist could therefore have therapeutic potential in RCC, with less risk of taste disturbances attributable to P2X2/3 receptor blockade [